BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22664751)

  • 1. Reduced graft-versus-host disease in C3-deficient mice is associated with decreased donor Th1/Th17 differentiation.
    Ma Q; Li D; Nurieva R; Patenia R; Bassett R; Cao W; Alekseev AM; He H; Molldrem JJ; Kroll MH; Champlin RE; Sale GE; Afshar-Kharghan V
    Biol Blood Marrow Transplant; 2012 Aug; 18(8):1174-81. PubMed ID: 22664751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement component C3 mediates Th1/Th17 polarization in human T-cell activation and cutaneous GVHD.
    Ma Q; Li D; Carreño R; Patenia R; Tsai KY; Xydes-Smith M; Alousi AM; Champlin RE; Sale GE; Afshar-Kharghan V
    Bone Marrow Transplant; 2014 Jul; 49(7):972-6. PubMed ID: 24777193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease.
    Yi T; Zhao D; Lin CL; Zhang C; Chen Y; Todorov I; LeBon T; Kandeel F; Forman S; Zeng D
    Blood; 2008 Sep; 112(5):2101-10. PubMed ID: 18596226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed death-1 pathway in host tissues ameliorates Th17/Th1-mediated experimental chronic graft-versus-host disease.
    Fujiwara H; Maeda Y; Kobayashi K; Nishimori H; Matsuoka K; Fujii N; Kondo E; Tanaka T; Chen L; Azuma M; Yagita H; Tanimoto M
    J Immunol; 2014 Sep; 193(5):2565-73. PubMed ID: 25080485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice.
    Wu Y; Bastian D; Schutt S; Nguyen H; Fu J; Heinrichs J; Xia C; Yu XZ
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1195-204. PubMed ID: 25846718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-bet is critical for the development of acute graft-versus-host disease through controlling T cell differentiation and function.
    Fu J; Wang D; Yu Y; Heinrichs J; Wu Y; Schutt S; Kaosaard K; Liu C; Haarberg K; Bastian D; McDonald DG; Anasetti C; Yu XZ
    J Immunol; 2015 Jan; 194(1):388-97. PubMed ID: 25404360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Rel is an essential transcription factor for the development of acute graft-versus-host disease in mice.
    Yu Y; Wang D; Kaosaard K; Liu C; Fu J; Haarberg K; Anasetti C; Beg AA; Yu XZ
    Eur J Immunol; 2013 Sep; 43(9):2327-37. PubMed ID: 23716202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease.
    Yi T; Chen Y; Wang L; Du G; Huang D; Zhao D; Johnston H; Young J; Todorov I; Umetsu DT; Chen L; Iwakura Y; Kandeel F; Forman S; Zeng D
    Blood; 2009 Oct; 114(14):3101-12. PubMed ID: 19602708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17.
    Nishimori H; Maeda Y; Teshima T; Sugiyama H; Kobayashi K; Yamasuji Y; Kadohisa S; Uryu H; Takeuchi K; Tanaka T; Yoshino T; Iwakura Y; Tanimoto M
    Blood; 2012 Jan; 119(1):285-95. PubMed ID: 22077062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-γ receptor-deficient donor T cells mediate protection from graft-versus-host disease and preserve graft-versus-tumor responses after allogeneic bone marrow transplantation.
    Sun K; Hsiao HH; Li M; Ames E; Bouchlaka M; Welniak LA; Hagino T; Jagdeo J; Pai CC; Chen M; Blazar BR; Abedi M; Murphy WJ
    J Immunol; 2012 Aug; 189(4):2033-42. PubMed ID: 22778394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine profiles in various graft-versus-host disease target organs following hematopoietic stem cell transplantation.
    Lai HY; Chou TY; Tzeng CH; Lee OK
    Cell Transplant; 2012; 21(9):2033-45. PubMed ID: 22840591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-L1 Ameliorates Murine Acute Graft-Versus-Host Disease by Suppressing Effector But Not Regulatory T Cells Function.
    Tang L; Ma S; Gong H; Wang J; Xu Y; Wu D; Sun A
    Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):179-187. PubMed ID: 30927016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deviated balance between Th1 and Th17 cells exacerbates acute graft-versus-host disease in mice.
    Pan B; Zhang Y; Sun Y; Cheng H; Wu Y; Song G; Chen W; Zeng L; Xu K
    Cytokine; 2014 Aug; 68(2):69-75. PubMed ID: 24845795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
    Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
    Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An absence of donor TH17 differentiation ameliorates dermal tissue damage].
    Cheng H; Song GL; Pan B; Tian J; Yan ZL; Chen W; Xu KL; Li ZY; Zeng LY
    Zhonghua Yi Xue Za Zhi; 2011 Jul; 91(26):1843-6. PubMed ID: 22093788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptively transferred donor IL-17-producing CD4
    Cai Y; Ma S; Liu Y; Gong H; Cheng Q; Hu B; Wu Y; Yu X; Dong C; Sun K; Wu D; Liu H
    Cell Mol Immunol; 2018 Mar; 15(3):233-245. PubMed ID: 27748733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstitution of interleukin-17-producing T helper cells after allogeneic hematopoietic cell transplantation.
    Bahr F; Wehner R; Platzbecker U; Wermke M; Shayegi N; Middeke JM; Röllig C; Schetelig J; Ehninger G; Schmitz M; Bornhäuser M; Tuve S
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):357-65. PubMed ID: 23207644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic Th1 cells home to host bone marrow and spleen and mediate IFNγ-dependent aplasia.
    Chewning JH; Zhang W; Randolph DA; Swindle CS; Schoeb TR; Weaver CT
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):876-87. PubMed ID: 23523972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory T cells and IL-17-producing cells in graft-versus-host disease.
    Teshima T; Maeda Y; Ozaki K
    Immunotherapy; 2011 Jul; 3(7):833-52. PubMed ID: 21751953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic Acid Ameliorates Graft-versus-Host Disease by Downregulating Th1 and Th17 Cells.
    Long J; Chang L; Shen Y; Gao WH; Wu YN; Dou HB; Huang MM; Wang Y; Fang WY; Shan JH; Wang YY; Zhu J; Chen Z; Hu J
    J Immunol; 2015 Aug; 195(4):1849-57. PubMed ID: 26179902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.